BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
105 results:

  • 1. The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis.
    Cai X; Li X; Liang C; Zhang M; Dong Z; Yu W
    Sci Rep; 2024 Apr; 14(1):9474. PubMed ID: 38658636
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer.
    Fang K; Wang J; Yuan J; Sui C; Zhi J; Xia Y; Sun M
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1952. PubMed ID: 38258341
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer.
    Li X; Wu M; Wu M; Liu J; Song L; Wang J; Zhou J; Li S; Yang H; Zhang J; Cui X; Liu Z; Zeng F
    Carcinogenesis; 2024 Mar; 45(3):170-180. PubMed ID: 38195111
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multivariate Prognostic Models for Patients with Stages I and Ii Colon Carcinoma: a Strobe-Compliant Retrospective Cohort Study.
    Oñate-Ocaña LF; Herrera-Goepfert R; Avilés-Salas A; Cortés CC; González-Trejo S; Carrillo JF; Ruiz-García E; Ochoa-Carrillo FJ; Aiello-Crocifoglio V; García-Cuellar CM
    Rev Invest Clin; 2023; 75(5):259-271. PubMed ID: 37918013
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    Cheraghi-Shavi T; Jalal R; Minuchehr Z
    PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Second primary cancer among 217702 colorectal cancer survivors: An analysis of national German cancer registry data.
    Liang LA; Tseng YJ; Tanaka LF; Klug SJ
    Int J Cancer; 2023 Oct; 153(8):1459-1471. PubMed ID: 37392091
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rectal cancer surgery: does low volume imply worse outcome-a single surgeon experience.
    Dundon NA; Al Ghazwi AH; Davey MG; Joyce WP
    Ir J Med Sci; 2023 Dec; 192(6):2673-2679. PubMed ID: 37154997
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy.
    Chen H; Yin L; Yang J; Ren N; Chen J; Lu Q; Huang Y; Feng Y; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
    Cancer Biol Med; 2023 May; 20(4):297-316. PubMed ID: 37144561
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study.
    Kosunen TU; Nieminen AA; Kokkola A; Arkkila P; Pukkala E; Rautelin H
    Helicobacter; 2023 Jun; 28(3):e12979. PubMed ID: 37009972
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicting Limited Survival After Resection of Synchronous colorectal Liver Metastases: a Propensity Score Matched Comparison Between The Primary First And The Simultaneous Strategy.
    Addeo P; Foguenne M; Guerra M; Cusumano C; Paul C; Faitot F; Fiore L; De Mathelin P; Bachellier P
    J Gastrointest Surg; 2023 Jun; 27(6):1141-1151. PubMed ID: 36857012
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study.
    Yagi K; Maruo A; Ishida S; Aizawa F; Ushio S; Sakaguchi S; Kajizono M; Niimura T; Goda M; Hamano H; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
    Clin Exp Med; 2023 Oct; 23(6):2799-2804. PubMed ID: 36738305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Cost-effectiveness Analysis of Adding Cetuximab to the First-line treatment of Metastatic colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine.
    Yousefi N; Salimi A; Mohammadnezhad G; Taheri S; Peiravian F
    J Gastrointest Cancer; 2023 Dec; 54(4):1212-1219. PubMed ID: 36622516
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. colorectal cancer trends in Chile: A Latin-American country with marked socioeconomic inequities.
    Mondschein S; Subiabre F; Yankovic N; Estay C; Von Mühlenbrock C; Berger Z
    PLoS One; 2022; 17(11):e0271929. PubMed ID: 36355864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sarcopenia does not limit overall survival in patients with colorectal liver metastases undergoing interstitial brachytherapy.
    Thormann M; Heitmann F; Wrobel V; Barajas Ordonez F; Pech M; Surov A; Damm R; Omari J
    Rofo; 2023 Mar; 195(3):217-223. PubMed ID: 36283404
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review.
    Castelo M; Sue-Chue-Lam C; Paszat L; Kishibe T; Scheer AS; Hansen BE; Baxter NN
    PLoS One; 2022; 17(9):e0273396. PubMed ID: 36094913
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against colorectal cancer.
    Zheng BB; Wang Q; Yue Y; Li J; Li XJ; Wang X
    Biomed Res Int; 2022; 2022():3008842. PubMed ID: 36046463
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With
    Rossini D; Antoniotti C; Lonardi S; Pietrantonio F; Moretto R; Antonuzzo L; Boccaccino A; Morano F; Brugia M; Pozzo C; Marmorino F; Bergamo F; Tamburini E; Passardi A; Randon G; Murgioni S; Borelli B; Buonadonna A; Giordano M; Fontanini G; Conca V; Formica V; Aglietta M; Bordonaro R; Aprile G; Masi G; Boni L; Cremolini C
    J Clin Oncol; 2022 Sep; 40(25):2878-2888. PubMed ID: 35666229
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Local resection versus radical resection for early-stage rectal cancer: a systematic review and meta-analysis.
    Tan S; Xu C; Ma H; Chen S; Yang Y; Zhan Y; Wu J; Sun Z; Ren B; Zhou Q; Cu Y
    Int J Colorectal Dis; 2022 Jul; 37(7):1467-1483. PubMed ID: 35622160
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Aldehyde Dehydrogenase 2 Family Member (aldh2) Is a Therapeutic Index for Oxaliplatin Response on colorectal cancer Therapy with Dysfunction p53.
    Wang WL; Batzorig U; Hung CS; Wei PL; Huang CY; Chang YJ
    Biomed Res Int; 2022; 2022():1322788. PubMed ID: 35178443
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.